RF

Ryan Fukushima

North America, United States

Description

Ryan Fukushima served as Chief Operating Officer at Tempus. Currently, he works at Pathos as CEO and co-founder. Mr. Fukushima earned his ba...

Investor Profile

Ryan Fukushima has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Pre Seed, Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Artificial Intelligence (AI), Software, Biotechnology.

Stage Focus

  • Pre Seed (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Software
  • Biotechnology
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ryan Fukushima frequently co-invest with?

Necessary Ventures
North America, California, United States, San Francisco
Co-Investments: 1
BI
Europe, Nordrhein-Westfalen, Germany, Gütersloh
Co-Investments: 1
Mucker Capital
North America, California, United States, Santa Monica
Co-Investments: 1
Meridian Street Capital
North America, New York, United States, New York
Co-Investments: 1
AIX Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Obvious Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Floating Point
North America, New York, United States, New York
Co-Investments: 1
Giant Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Founders Fund
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does Ryan Fukushima often collaborate with?

MS
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Ryan Fukushima?

Ataraxis

New York, New York, United States

Ataraxis is an AI-based diagnostic platform that helps develop personalized treatment plans.

Artificial Intelligence (AI)BiotechnologyHealth DiagnosticsSoftware
Series AMar 5, 2025
Amount Raised: $20,400,000
Readout AI

La Canada Flintridge, California, United States

Readout.ai provides AI tools for analyzing preclinical and clinical trial data, automatically.

Artificial Intelligence (AI)Software
Pre SeedJul 14, 2023
Amount Raised: $1,670,002